Little Paul Sean has filed 6 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 175000 shares of Eledon Pharmaceuticals, Inc. ($ELDN) on January 10, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 10, 2025 | Eledon Pharmaceuticals, Inc. | $ELDN | Little Paul Sean | Chief Financial Officer | A | Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 48,543,787 | 9999.99% | 0.36% |
| Jan. 10, 2025 | Eledon Pharmaceuticals, Inc. | $ELDN | Little Paul Sean | Chief Financial Officer | A | Restricted Stock Units | 75000 | $0.00 | 75,000.0000 | 48,543,787 | 9999.99% | 0.15% |
| Nov. 21, 2024 | Eledon Pharmaceuticals, Inc. | $ELDN | Little Paul Sean | Chief Financial Officer | A | Stock Option (right to buy) | 525032 | $0.00 | 525,032.0000 | 51,945,920 | 9999.99% | 1.01% |
| June 13, 2024 | Eledon Pharmaceuticals, Inc. | $ELDN | Little Paul Sean | Chief Financial Officer | A | Stock Option (right to buy) | 267470 | $0.00 | 267,470.0000 | 24,619,197 | 9999.99% | 1.09% |
| May 1, 2023 | Eledon Pharmaceuticals, Inc. | $ELDN | Little Paul Sean | Chief Financial Officer | A | Stock Option (right to buy) | 198126 | $0.00 | 198,126.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2023 | Eledon Pharmaceuticals, Inc. | $ELDN | Little Paul Sean | Chief Financial Officer | A | Stock Option (right to buy) | 155000 | $0.00 | 155,000.0000 | 0 | 9999.99% | 0.00% |